The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research.

If you live in the United States, odds are high that a tiny passenger rides in your blood. By adulthood, more than 94 percent ...

A phase 1 trial reveals that combining radiotherapy with immunotherapy enhances response rates in B-cell lymphomas while maintaining manageable safety profiles.

During a live event, Thomas G. Martin, MD, discussed updated findings from the CARTITUDE-1 trial of cilta-cel and what they signify for patients with no disease progression at 5 years.

A new international multicenter study published in the Journal of Cellular and Molecular Medicine provides important real-world evidence on the use of CD19-targeted chimeric antigen receptor (CAR) ...

In a town on the shores of Lake Geneva sit clumps of living human brain cells for hire. These blobs, about the size of a ...

A peek inside some leading research labs shows how scientists-turned-detectives are painstakingly decoding what causes ...

Early CAR T cell expansion is associated with both therapeutic activity and inflammatory toxicity, such as cytokine release syndrome and neurotoxicity. Routine flow cytometry can reliably track ...

Charles Longshore distinctly remembers the tipping point that led his Alabama middle school to ban cell phones, two years ...

Around 25 million Americans have a rare genetic disease, and many of them struggle with not only a lack of effective ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...